CN100482636C - 取代的辛酰胺的制备方法 - Google Patents
取代的辛酰胺的制备方法 Download PDFInfo
- Publication number
- CN100482636C CN100482636C CNB018122817A CN01812281A CN100482636C CN 100482636 C CN100482636 C CN 100482636C CN B018122817 A CNB018122817 A CN B018122817A CN 01812281 A CN01812281 A CN 01812281A CN 100482636 C CN100482636 C CN 100482636C
- Authority
- CN
- China
- Prior art keywords
- alkyl
- compound
- general formula
- reaction
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
Abstract
Description
Claims (7)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1329/00 | 2000-07-05 | ||
CH1329/2000 | 2000-07-05 | ||
CH13292000 | 2000-07-05 | ||
CH2450/2000 | 2000-12-15 | ||
CH2450/00 | 2000-12-15 | ||
CH24502000 | 2000-12-15 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101088576A Division CN100526304C (zh) | 2000-07-05 | 2001-06-26 | 取代的辛酰胺的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1440381A CN1440381A (zh) | 2003-09-03 |
CN100482636C true CN100482636C (zh) | 2009-04-29 |
Family
ID=25738979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB018122817A Expired - Lifetime CN100482636C (zh) | 2000-07-05 | 2001-06-26 | 取代的辛酰胺的制备方法 |
Country Status (24)
Country | Link |
---|---|
US (1) | US6730798B2 (zh) |
EP (1) | EP1296935B1 (zh) |
JP (1) | JP4900755B2 (zh) |
KR (1) | KR100690471B1 (zh) |
CN (1) | CN100482636C (zh) |
AR (1) | AR029564A1 (zh) |
AT (1) | ATE426592T1 (zh) |
AU (2) | AU2001273763B2 (zh) |
BR (1) | BR0112362B1 (zh) |
CA (1) | CA2414847C (zh) |
CY (1) | CY1109110T1 (zh) |
DE (1) | DE60138099D1 (zh) |
DK (1) | DK1296935T3 (zh) |
ES (1) | ES2322547T3 (zh) |
HK (1) | HK1093201A1 (zh) |
HU (1) | HU228526B1 (zh) |
IL (4) | IL153717A0 (zh) |
MX (1) | MXPA02012628A (zh) |
NO (1) | NO328105B1 (zh) |
NZ (1) | NZ523088A (zh) |
PL (1) | PL212898B1 (zh) |
PT (1) | PT1296935E (zh) |
TW (1) | TWI289551B (zh) |
WO (1) | WO2002002508A1 (zh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060154926A1 (en) * | 2002-06-11 | 2006-07-13 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease using aryl alkanoic acid amides |
GB0419361D0 (en) | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
GB0511686D0 (en) | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
RU2470018C2 (ru) * | 2005-07-11 | 2012-12-20 | Новартис Аг | Новые производные пирокатехина |
GB0519764D0 (en) | 2005-09-28 | 2005-11-09 | Novartis Ag | Organic compounds |
GB2431649A (en) * | 2005-10-25 | 2007-05-02 | Novartis Ag | Alternative synthesis of aryl-octanoyl amide compounds |
GB2431645A (en) * | 2005-10-25 | 2007-05-02 | Novartis Ag | Alternative synthesis of aryl-octanoyl amide compounds |
DE102005052195A1 (de) | 2005-10-28 | 2007-05-03 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von chiralen Octensäurederivaten |
GB0605688D0 (en) | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
PE20081157A1 (es) * | 2006-11-07 | 2008-09-26 | Novartis Ag | Forma cristalina de hemifumarato de alisquireno |
BRPI0718701A2 (pt) * | 2006-11-09 | 2013-12-31 | Novartis Ag | Sal de alisquireno com ácido orótico |
EP1958666A1 (en) | 2007-02-13 | 2008-08-20 | Speedel Experimenta AG | Heterocyclic-substituted alkanamides as therapeutic compounds |
DE102007049039A1 (de) | 2007-10-11 | 2009-04-16 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung |
EP2220031A1 (en) * | 2007-11-13 | 2010-08-25 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of aliskiren hemifumarate and process for preparation thereof |
EP2062874B1 (en) | 2007-11-20 | 2014-12-17 | KRKA, tovarna zdravil, d.d., Novo mesto | Process and intermediates for the preparation of aliskiren |
WO2009143423A1 (en) * | 2008-05-23 | 2009-11-26 | Teva Pharmaceutical Industries Ltd. | Aliskiren monofumarate and processes for preparation thereof |
EP2189442B1 (en) | 2008-11-20 | 2014-10-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process and intermediates for the preparation of aliskiren |
WO2010089105A2 (en) | 2009-02-05 | 2010-08-12 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Moisture-activated granulation process |
EP2273990A2 (en) * | 2009-02-05 | 2011-01-19 | Teva Pharmaceutical Industries Ltd. | Solid state forms of aliskiren compounds |
WO2011028919A2 (en) | 2009-09-03 | 2011-03-10 | Teva Pharmaceutical Industries Ltd. | Solid forms of aliskiren hemifumarate and processes for preparation thereof |
WO2011051853A1 (en) | 2009-10-29 | 2011-05-05 | CarboDesign LLC | Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren |
US20110113995A1 (en) * | 2009-11-13 | 2011-05-19 | Lindsay Corporation | Method and apparatus for planting and irrigation |
WO2011148392A1 (en) * | 2010-05-28 | 2011-12-01 | Msn Laboratories Limited | Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof |
WO2012052829A1 (en) | 2010-10-19 | 2012-04-26 | Matrix Laboratories Ltd | Synthesis of aliskiren |
ITMI20110893A1 (it) * | 2011-05-19 | 2012-11-20 | Chemelectiva S R L | Processi ed intermedi per la sintesi di aliskiren |
EP2551260A1 (en) | 2011-07-28 | 2013-01-30 | Chemo Ibérica, S.A. | Chemical process for opening ring compounds |
US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
WO2013118138A1 (en) | 2011-12-13 | 2013-08-15 | Laboratories Ltd Mylan | Novel process for the preparation of renin inhibitors |
US9090537B2 (en) | 2012-02-17 | 2015-07-28 | Mylan Laboratories Limited | Process for the preparation of aliskiren |
WO2013124868A2 (en) | 2012-02-21 | 2013-08-29 | Mylan Laboratories Limited | Solid form of aliskiren intermediate |
WO2013144979A1 (en) | 2012-03-28 | 2013-10-03 | Maylan Laboratories Ltd | Process for the preparation of aliskiren |
WO2013171767A1 (en) | 2012-05-18 | 2013-11-21 | Mylan Laboratories Limited | An improved process for the preparation of aliskiren |
CN104876832B (zh) * | 2014-02-28 | 2016-12-07 | 华润双鹤药业股份有限公司 | 阿利吉仑的4-位差向异构体、其制备方法及用途 |
CN106146339B (zh) * | 2015-04-23 | 2018-02-23 | 华润双鹤药业股份有限公司 | 阿利吉仑的5‑位差向异构体、其制备方法及用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0678503B1 (de) * | 1994-04-18 | 1999-09-01 | Novartis AG | Delta-Amino-gamma-hydroxy-omega-aryl-alkansäureamide mit Enzym-, insbesondere Renin-hemmenden Eigenschaften |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4492799A (en) * | 1979-07-02 | 1985-01-08 | Union Carbide Corporation | Halo-4-alkenoic acids and their use as pesticidal intermediates |
FR2666757B1 (fr) * | 1990-09-14 | 1992-12-18 | Usinor Sacilor | Virole pour cylindre de coulee continue des metaux, notamment de l'acier, entre cylindres ou sur un cylindre. |
US5606078A (en) | 1994-04-18 | 1997-02-25 | Ciba-Geigy Corporation | 3,5-Disubstituted tetrahydrofuran-2-ones |
US5659065A (en) * | 1994-04-18 | 1997-08-19 | Novartis Corporation | Alpha-aminoalkanoic acids and reduction products |
WO1996002340A1 (de) * | 1994-07-18 | 1996-02-01 | Siemens Aktiengesellschaft | Giesswalzen-verschleissschutzschicht |
WO1998052706A1 (de) * | 1997-05-23 | 1998-11-26 | Voest-Alpine Industrieanlagenbau Gmbh | Giesswalze für eine dünnband-stranggiessanlage |
ES2218173T3 (es) * | 1999-07-29 | 2004-11-16 | Speedel Pharma Ag | Acidos 2-alquil-5-halogano-pent-4-enocarboxilicos y su fabricacion. |
-
2001
- 2001-06-26 ES ES01940047T patent/ES2322547T3/es not_active Expired - Lifetime
- 2001-06-26 AU AU2001273763A patent/AU2001273763B2/en not_active Ceased
- 2001-06-26 WO PCT/CH2001/000399 patent/WO2002002508A1/en active Application Filing
- 2001-06-26 NZ NZ523088A patent/NZ523088A/en not_active IP Right Cessation
- 2001-06-26 US US10/312,987 patent/US6730798B2/en not_active Expired - Lifetime
- 2001-06-26 DE DE60138099T patent/DE60138099D1/de not_active Expired - Lifetime
- 2001-06-26 CN CNB018122817A patent/CN100482636C/zh not_active Expired - Lifetime
- 2001-06-26 JP JP2002507765A patent/JP4900755B2/ja not_active Expired - Lifetime
- 2001-06-26 AT AT01940047T patent/ATE426592T1/de active
- 2001-06-26 HU HU0301463A patent/HU228526B1/hu not_active IP Right Cessation
- 2001-06-26 CA CA002414847A patent/CA2414847C/en not_active Expired - Fee Related
- 2001-06-26 KR KR1020027017207A patent/KR100690471B1/ko active IP Right Grant
- 2001-06-26 IL IL15371701A patent/IL153717A0/xx unknown
- 2001-06-26 PL PL358887A patent/PL212898B1/pl unknown
- 2001-06-26 EP EP01940047A patent/EP1296935B1/en not_active Expired - Lifetime
- 2001-06-26 PT PT01940047T patent/PT1296935E/pt unknown
- 2001-06-26 AU AU7376301A patent/AU7376301A/xx active Pending
- 2001-06-26 BR BRPI0112362-9B1A patent/BR0112362B1/pt not_active IP Right Cessation
- 2001-06-26 MX MXPA02012628A patent/MXPA02012628A/es active IP Right Grant
- 2001-06-26 DK DK01940047T patent/DK1296935T3/da active
- 2001-06-29 TW TW090115929A patent/TWI289551B/zh not_active IP Right Cessation
- 2001-07-04 AR ARP010103194A patent/AR029564A1/es active IP Right Grant
-
2002
- 2002-12-27 IL IL153717A patent/IL153717A/en not_active IP Right Cessation
-
2003
- 2003-01-02 NO NO20030012A patent/NO328105B1/no not_active IP Right Cessation
-
2006
- 2006-12-19 HK HK06113953.2A patent/HK1093201A1/xx not_active IP Right Cessation
-
2007
- 2007-11-29 IL IL187795A patent/IL187795A/en not_active IP Right Cessation
- 2007-11-29 IL IL187796A patent/IL187796A/en not_active IP Right Cessation
-
2009
- 2009-05-28 CY CY20091100571T patent/CY1109110T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0678503B1 (de) * | 1994-04-18 | 1999-09-01 | Novartis AG | Delta-Amino-gamma-hydroxy-omega-aryl-alkansäureamide mit Enzym-, insbesondere Renin-hemmenden Eigenschaften |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100482636C (zh) | 取代的辛酰胺的制备方法 | |
AU2001273763A1 (en) | Process for the preparation of substituted octanoyl amides | |
CN103641731A (zh) | 苯基乙酰胺化合物的制造方法 | |
WO2010113939A1 (ja) | ジフェニルメタン化合物 | |
CN102869644B (zh) | 用于制备他喷他多及其中间体的方法 | |
KR20070115896A (ko) | (z)-1-페닐-1-(n,n-디에틸아미노카르보닐)-2-프탈이미도메틸시클로프로판의 제조 방법 | |
CA2670282A1 (en) | A new method for preparing 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione) | |
CN101016253A (zh) | 高血压蛋白原酶抑制剂阿利克仑的实用性合成方法 | |
CN109824547A (zh) | 一种双不同保护氨基酸的合成方法 | |
CN100526304C (zh) | 取代的辛酰胺的制备方法 | |
US7321055B2 (en) | Production method of optically active dephenylalanine compounds | |
CN101875615A (zh) | 一种高选择性制备叔亮氨酸的方法 | |
JP5301676B2 (ja) | (3s,4s)−4−((r)−2−(ベンジルオキシ)トリデシル)−3−ヘキシル−2−オキセタノンの製造方法及びそれに用いられる新規な中間体 | |
Tsubaki et al. | Convenient synthesis and efficient resolution of 3, 3′-bis (benzyloxy)-1, 1′-binaphthalene-2, 2′-diol | |
WO2014181362A1 (en) | A process for the preparation of 3-aryl-2-hydroxy propanoic acid compounds | |
CN102971297A (zh) | 匹伐他汀或其盐的中间体的制备方法 | |
JP2004238322A (ja) | (r)−3−アミノペンタンニトリルメタンスルホン酸塩の製造方法 | |
CN101535287B (zh) | 合成n-[3-[(2-甲氧基苯基)硫烷基]-2-甲基丙基]-3,4-二氢-2h-1,5-苯并氧硫杂*-3-胺的方法 | |
WO2006083010A1 (ja) | 4−アセチルピリミジン化合物の製造方法およびその結晶 | |
JP2008169204A (ja) | (1r,2r)−2−アミノ−1−シクロペンタノールの製造方法 | |
CN102675198B (zh) | 一种制备和纯化4‑(4‑氨基苯氧基)‑n‑甲基吡啶‑2‑甲酰胺的方法 | |
AU759591B2 (en) | New process | |
KR100834387B1 (ko) | 벤즈아미드 유도체의 신규한 제조방법 및 그 중간체 | |
JP2009035508A (ja) | 光学活性カルボン酸の製造方法 | |
JP2002088057A (ja) | 光学活性な3−ヒドロキシピロリジン類の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170509 Address after: Dublin, Ireland Patentee after: Norton pharmaceuticals Address before: Basel, Switzerland Patentee before: Novartis Pharmaceutical Co.,Ltd. Effective date of registration: 20170509 Address after: Basel, Switzerland Patentee after: Novartis Pharmaceutical Co.,Ltd. Address before: Basel, Switzerland Patentee before: Speedel Pharma AG |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20090429 |
|
CX01 | Expiry of patent term |